| Cheville, Andrea Lynne |
Mayo Clinic Rochester
United States |
Achieving Safe, Comprehensive, Digitally-Enabled Cancer Pain managemeNT” (ASCENT) Clinical Trial |
5R33CA278594-04 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Chiang, Cheng-Ming |
Ut Southwestern Medical Center
United States |
Small Compound Inhibitors Targeting HPV Genome Replication |
5R01CA288743-02 |
|
Anda Vlad, M.D., Ph.D. |
| Chinnaiyan, Arul M |
University Of Michigan At Ann Arbor
United States |
Michigan-VUMC Biomarker Characterization Center |
5U2CCA271854-04 |
|
Indu Kohaar, Ph.D., M.Phil., M.Sc. |
| Chirenje, Zvavahera Mike |
University Of California, San Francisco
United States |
Implementing HIV/Cervical Cancer Prevention CASCADE Clinical Trials in Zimbabwe (ZIM-CASCADE) |
3UG1CA284918-03S1 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Chung, Raymond T |
Massachusetts General Hospital
United States |
Trial of Statins for Chemoprevention in Hepatocellular Carcinoma |
4R01CA255621-05 |
|
Asad Umar, D.V.M., Ph.D. |
| Chung, Michael Hoonbae |
Emory University
United States |
HIV/cervical cancer cOntrol and Prevention clinical sitE in Kenya (HOPE-Kenya) |
3UG1CA275400-04S1 |
|
Maria Silvina Frech, Ph.D., M.S. |
| Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis |
5R01CA262551-04 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Nancy J. Emenaker, Ph.D., RDN, LD, FAND |
| Clapper, Margie L. |
Research Inst Of Fox Chase Can Ctr
United States |
Cancer Prevention-Interception Targeted Agent Discovery Program at Fox Chase Cancer Center |
5U54CA272686-04 |
|
John Clifford, Ph.D. |
| Clare, Susan E. |
Northwestern University At Chicago
United States |
Lipid-initiated epigenetic reprogramming of the breast to a neural phenotype |
5R21CA288676-02 |
|
John Clifford, Ph.D. |
| Cocucci, Emanuele |
Ohio State University
United States |
A SYNTHETIC BIOMARKER TO UNIVERSALLY ASSESS THE RELATIVE CONTRIBUTION OF HEATHY AND CANCEROUS TISSUE TO CIRCULATING EV POOL |
5R01CA270251-04 |
PAR-20-053 (R01 Clinical Trial Not Allowed) |
Matthew Young, Ph.D. |
